Retinal imaging technology has potential in detecting Alzheimer's

Article

Medical retinal imaging company Optos found that monitoring the peripheral section of the retina could play a vital role in the detection of Alzheimer's Dementia (AD).

Medical retinal imaging company Optos found that monitoring the peripheral section of the retina could play a vital role in the detection of Alzheimer's Dementia (AD).

The investigation was part of 20 positive clinical studies announced at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) held in Fort Lauderdale, Florida, USA, 1–4 May.

A team led by Dr Tunde Peto et al., Moorfield's Eye Hospital, London, captured optomap retinal images of 102 patients (56 AD sufferers and 46 age-matched controls) to determine whether a simple eye exam could be used for screening purposes. Optos ultra wide field images were used during the screen test to identify drusen within the retina.

The findings demonstrated a high correlation between AD and peripheral, small, hard drusen formation. This suggests that examining the peripheral section of the retina could be an essential part of detecting and examining the progression of AD.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
© 2025 MJH Life Sciences

All rights reserved.